AC Immune (ACIU) Change in Accured Expenses (2015 - 2025)

AC Immune (ACIU) has reported Change in Accured Expenses for 11 consecutive years, with -$4.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 328.95% year-over-year to -$4.7 million; the TTM figure through Dec 2025 stood at -$4.7 million (down 407.74% YoY), while the FY2025 annual figure was -$4.7 million, down 397.12% from the prior year.
• Change in Accured Expenses slipped to -$4.7 million in Q4 2025 per ACIU's latest filing, from $645056.5 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.3 million in Q4 2021 and bottomed at -$5.6 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$55722.4 across 5 years, with a median of $399811.7 in 2025.
• Annual changes were most pronounced in 2021 — Change in Accured Expenses jumped 4222.27% — and 2025, when it sank 3746.87%.
• AC Immune's Change in Accured Expenses stood at $3.3 million in 2021, then sank by 83.23% to $561217.5 in 2022, then surged by 148.08% to $1.4 million in 2023, then slumped by 178.71% to -$1.1 million in 2024, then tumbled by 328.95% to -$4.7 million in 2025.
• Business Quant data shows ACIU's Change in Accured Expenses at -$4.7 million in Q4 2025, $645056.5 in Q3 2025, and $399811.7 in Q2 2025.